Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac

被引：10
作者：
Díaz-Montes, TP
Jacene, HA
Wahl, RL
Bristow, RE
机构：
[1] Johns Hopkins Med Inst, Dept Gynecol & Obstet, Kelly Gynecol Oncol Serv, Baltimore, MD 21287 USA
[2] Johns Hopkins Med Inst, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA
来源：
GYNECOLOGIC ONCOLOGY | 2005年 / 98卷 / 03期
关键词：
ovarian cancer; inguinal hernia; recurrence; FDG; positron emission tomography; computed tomography;
D O I：
10.1016/j.ygyno.2005.05.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background. Ovarian cancer recurrence presenting in an inguinal hernia sac is rare. Only I case of malignant ovarian cancer growing into an inguinal hernia sac has been reported in the English literature. Combined positron emission tomography (PET) and computed tomography (CT) may have a potential role in the early detection and anatomical localization of recurrent ovarian cancer. Case report. This is the first case of occult metastasis from ovarian cancer recurrence growing in a right inguinal hernia sac identified using combined FDG-PET/CT. Conclusion. Preoperative combined FDG-PET/CT imaging may have utility in the detection and anatomic localization of occult ovarian cancer recurrence, which may increase the likelihood of complete resection. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码：510 / 512
页数：3
相关论文
共 10 条
[1]  
BEREK JS, 2000, PRACTICAL GYNECOLOGI, P495
[2]   Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT [J].
Bristow, RE ;
del Carmen, MG ;
Pannu, HK ;
Cohade, C ;
Zahurak, ML ;
Fishman, EK ;
Wahl, RL ;
Montz, FJ .
GYNECOLOGIC ONCOLOGY, 2003, 90 (03) :519-528
[3]  
DISAIA PJ, 2002, CLIN GYNECOLOGICA ON, P329
[4]   Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma [J].
Kubik-Huch, RA ;
Dörffler, W ;
von Schulthess, GK ;
Marincek, B ;
Köchli, OR ;
Seifert, B ;
Haller, U ;
Steinert, HC .
EUROPEAN RADIOLOGY, 2000, 10 (05) :761-767
[5]   PREDICTIVE VALUE OF CA-125 ANTIGEN LEVELS IN 2ND-LOOK PROCEDURES FOR OVARIAN-CANCER [J].
NILOFF, JM ;
BAST, RC ;
SCHAETZL, EM ;
KNAPP, RC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 151 (07) :981-986
[6]   PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation [J].
Pannu, HK ;
Cohade, C ;
Bristow, RE ;
Fishman, EK ;
Wahl, RL .
ABDOMINAL IMAGING, 2004, 29 (03) :398-403
[7]   SECONDARY CYTOREDUCTION FOR OVARIAN-CANCER FOLLOWING CISPLATIN THERAPY [J].
SEGNA, RA ;
DOTTINO, PR ;
MANDELI, JP ;
KONSKER, K ;
COHEN, CJ .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :434-439
[8]  
STRAUSS LG, 1991, J NUCL MED, V32, P623
[9]   Malignant mixed mullerian tumor of the ovary growing into an inguinal hernia sac: Report of a case [J].
Takeuchi, K ;
Tsuzuki, Y ;
Ando, T ;
Sekihara, M ;
Hara, T ;
Kori, T ;
Kawakami, T ;
Ohno, Y ;
Kuwano, H .
SURGERY TODAY, 2003, 33 (10) :797-800
[10]   Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose [J].
Torizuka, T ;
Nobezawa, S ;
Kanno, T ;
Futatsubashi, M ;
Yoshikawa, E ;
Okada, H ;
Takekuma, M ;
Maeda, M ;
Ouchi, Y .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (06) :797-803
1